Skip to main content
Account

Peer review reports

From: The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy

Original Submission
17 May 2024 Submitted Original manuscript
25 May 2024 Author responded Author comments - San-Gang Wu
10 Jun 2024 Reviewed Reviewer Report
23 Jun 2024 Reviewed Reviewer Report
1 Jul 2024 Author responded Author comments - San-Gang Wu
Resubmission - Version 2
25 May 2024 Submitted Manuscript version 2
10 Jul 2024 Reviewed Reviewer Report
28 Jul 2024 Author responded Author comments - San-Gang Wu
Resubmission - Version 3
28 Jul 2024 Submitted Manuscript version 3
Publishing
30 Jul 2024 Editorially accepted
2 Aug 2024 Article published 10.1186/s12885-024-12731-7

Learn about peer review

Back to article page

Navigation